Ta­laris dis­con­tin­ues two tri­als, cuts staff and starts ‘strate­gic al­ter­na­tives’ search

Ta­laris Ther­a­peu­tics said it will be stop­ping two clin­i­cal tri­als of its stem cell ther­a­py, meant to re­duce the need for im­muno­sup­pres­sion in kid­ney trans­plant …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER